Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of α-SMA and NF-κB

International Immunology

Volumn 17, Issue 11, 2005, Pages 1473-1481

  Baouz, Soria ^a   Giron Michel, Julien ^a   Azzarone, Bruno ^a   Giuliani, Massimo ^a   Cagnoni, Francesca ^b   Olsson, Susanna ^b   Testi, Renato ^c   Gabbiani, Giulio ^d   Canonica, G Walter ^b  

^a HÔPITAL PAUL BROUSSE   (France)

^b UNIVERSITY OF GENOA   (Italy)

^c GSK   (Italy)

^d UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

2 agonists; Airway inflammation; Airway remodelling; Asthma

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROPRANOLOL; SALMETEROL; TRANSFORMING GROWTH FACTOR BETA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RESPONSE; DRUG TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; LUNG FIBROBLAST; LUNG FUNCTION; MUSCLE ISOMETRIC CONTRACTION; MYOFIBROBLAST; PRIORITY JOURNAL;

ACTINS; ACTIVE TRANSPORT, CELL NUCLEUS; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; ASTHMA; CELLS, CULTURED; CYTOKINES; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; LUNG; MYOBLASTS, SMOOTH MUSCLE; NF-KAPPA B;

EID: 27744441314     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxh325     Document Type: Article

References (38)

1. Gizycki, M. J., Adelroth, E., Rogers, A. V., O'Byrne, P. M. and Jeffery, P. K. 1997. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am. J. Respir. Cell Mol. Biol. 16:664.
2. Barnes, P. J. 1998. Pharmacology of airway smooth muscle. Am. J. Respir. Crit. Care Med. 158:S123.
3. Roche, W. R., Beasley, R., Williams, J. H. and Holgate, S. T. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1:520.
4. Davies, D. E., Wicks, J., Powell, R. M., Puddicombe, S. M. and Holgate, S. T. 2003. Airway remodeling in asthma: New insights. J. Allergy Clin. Immunol. 111:215.
5. Smith, R. S., Smith, T. J., Blieden, T. M. and Phipps, R. P. 1997. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am. J. Pathol. 151:317.
6. Hogaboam, C. M., Bone-Larson, C. L., Lipinski, S. et al. 1999. Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models. J. Immunol. 163:2193.
7. Rochester, C. L., Ackerman, S. J., Zheng, T. and Elias, J. A. 1996. Eosinophil-fibroblast interactions - granule major basic protein interacts with IL-1 and transforming growth factor-β in the stimulation of lung fibroblast IL-6-type cytokine production. J Immunol. 156:4449.
8. Doucet, C., Brouty-Boyé, D., Pottin-Clemenceau, C., Canonica, W., Jasmin, C. and Azzarone, B. 1998. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J. Clin. Invest. 101:2129.
9. Richter, A., Puddicombe, S. M., Lordan, J. L. et al. 2001. The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma. Am. J. Respir. Cell Mol. Biol. 125:385.
10. Markham, A. and Jarvis, B. 2000. Inhaled salmeterol/fluticasone propionate combination: A review of its use in persistent asthma. Drugs 60:1207.
11. Pauwels, R. A., Lofdahl, C. G., Laitinen, L. A. et al. 1997. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N. Engl. J. Med. 337:1405.
12. 2-agonists and corticosteroids. FASEB J. 15:261.
13. Barnes, P. J. 2000. Molecular mechanisms of glucocorticoid action in asthma. Chem. Immunol. 78:72.
14. Spoelstra, F. M., Postma, D. S., Hovenga, H., Noordhoek, J. A. and Kauffman, H. F. 2002. Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts. Thorax 57:237.
15. Spoelstra, F. M., Kauffman, H. F., Hovenga, H., Noordhoek, J. A., de Monchy, J. G. and Postma, D. S. 2000. Effects of budesonide and formoterol on eosinophil activation induced by human lung fibroblasts. Am. J. Respir. Crit. Care Med. 162:1229.
16. Fitzgerald, S. M., Chi, D. S., Lee, S. A., Hall, K. and Krishnaswamy, G. 2004. Inhibition of GM-CSF production in fibroblast-monocyte coculture by prednisone and effects of rhGM-CSF on human lung fibroblasts. Front. Biosci. 9:342.
17. Wilkinson, T. S., Potter-Perigo, S., Tsoi, C., Altman, L. C. and Wight, T. N. 2004. Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 31:92.
18. Cazes, E., Giron-Michel, J., Baouz, S. et al. 2001. Novel anti-inflammatory effects of the inhaled corticosteroid fluticasone propionate during lung myofibroblastic differentiation. J. Immunol. 167:5329.
19. Ewing, C. K., Duffy, D. M. and Roberts, J. M. 1992. Characterization of the beta-adrenergic receptor in isolated human fetal lung type II cells. Pediatr. Res. 32:350.
20. Lindenschmidt, R. C. and Witschi, H. P. 1985. Propranolol-induced elevation of pulmonary collagen. J. Pharmacol. Exp. Ther. 232:346.
21. Arora, P. D., Narani, N. and McCulloch, C. A. 1999. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am. J. Pathol. 54:871.
22. Hinz, B., Mastrangelo, D., Iselin, C. E., Chaponnier, C. and Gabbiani, G. 2001. Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am. J. Pathol. 9:1009.
23. Ek, A., Larsson, K., Siljerud, S. and Palmberg, L. 1999. Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages. Allergy 54:691.
24. Osborn, L., Kunkel, S. and Nabel, G. J. 1989. Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc. Natl Acad. Sci. USA 86:2336.
25. Bonizzi, G., Dejardin, E., Piret, B., Piette, J., Merville, M. P. and Bours, V. 1996. Interleukin-1 beta induces nuclear factor kappa B in epithelial cells independently of the production of reactive oxygen intermediates. Eur. J. Biochem. 242:544.
26. Harris, A. K., Wild, P. and Stopak, D. 1980. Silicone rubber substrate: a new wrinkle in the study of cell locomotion. Science 208:177.
27. Hinz, B., Gabbiani, G. and Chaponnier, C. 2002. The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo. J. Cell Biol. 157:657.
28. Barja, F., Coughlin, C., Belin, D. and Gabbiani, G. 1986. Actin isoform synthesis and mRNA levels in quiescent and proliferating rat aortic smooth muscle cells in vivo and in vitro. Lab. Investig. 55:226.
29. Tomita, N., Morishita, R., Tomita, S. et al. 2001. Inhibition of TNF-alpha, induced cytokine and adhesion molecule. Expression in glomerular cells in vitro and in vivo by transcription factor decoy for NFkappaB. Exp. Nephrol. 9:181.
30. Li, X., Ward, C., Thien, F. et al. 1999. An anti-inflammatory effect of salmeterol, a long-acting beta (2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma. Am. J. Respir. Crit. Care Med. 160:1493.
31. Wilson, S. J., Wallin, A., Della-Cioppa, G., Sandstrom, T. and Holgate, S. T. 2001. Effects of budesonide and formoterol on NF-κB, adhesion molecules, and cytokines in asthma. Am. J. Respir. Crit. Care Med. 164:1047.
32. Eickelberg, O., Roth, M., Lorx, R. et al. 1999. Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J. Biol. Chem. 274:1005.
33. Spoelstra, F. M., Postma, D. S., Hovenga, H., Noordhoek, J. A. and Kauffman, H. F. 2000. Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts. Eur. Respir. J. 15:68.
34. Shoji, T., Nakanishi, I., Suzuki, A. et al. 2000. Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy. Am. J. Kidney Dis. 35:194.
35. Barnes, P. J. 2003. Therapy of chronic obstructive pulmonary disease. Pharmacol. Ther. 97:87.
36. Jeffery, P. 1998. Structural alterations and inflammation of bronchi in asthma. Int. J. Clin. Pract. Suppl. 96:5.
37. Doucet, C., Giron-Michel, J., Canonica, G. W. and Azzarone, B. 2002. Human lung myofibroblasts as effectors of the inflammatory process: The common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha. Eur. J. Immunol. 32:2437.
38. Hogaboam, C. M., Smith, R. E. and Kunkel, S. L. 1998. Dynamic interactions between lung fibroblasts and leukocytes: Implications for fibrotic lung diseases. Proc. Assoc. Am. Physicians. 110:313.